• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMC
Click for more information
0.00% 10.0¢

IMMURON LIMITED - Charts / Financials

Market Cap $22.8M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Immuron Limited is an Australia-based biopharmaceutical company focused on developing and... Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects in Australia, Israel and the United States. The Company's flagship commercial products consist of Travelan and Protectyn. Travelan is an over the counter orally administered passive immunotherapeutic product indicated to reduce the risk of travelers' diarrhea, reduce the risk of minor gastro-intestinal disorders and is antimicrobial. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. The Company has four clinical programs -Travelan (IMM-124E), CampETEC, IMM-529 and Travelan (consumer product).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.40pm 30/04/2024 (20 minute delay) ?
Day
Open 10.0¢   Day High 10.0¢   Day Low 9.9¢
Daily Volume 166832
Bids   Sellers
Number Price Volume   Number Price Volume
1 9.9¢ 29183   10 10.5¢ 249372

Directors & Senior Management

Mr. Steven Lydeamore Chief Executive Officer
Mr. Phillip Hains Chief Financial Officer, Company Secretary
Dr. Jerry Kanellos Chief Operating Officer
Mr. Paul Brennan Non-Executive Independent Chairman of the Board
Dr. Roger Aston Non-Executive Director
Mr. Daniel Pollock Non-Executive Independent Director
Mr. Stephen Anastasiou Non-Executive Independent Director
Prof. Ravi Savarirayan Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
10.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $22.8M
Open High Low Value Volume
10.0¢ 10.0¢ 9.9¢ $16.68K 166.8K

Buyers (Bids)

No. Vol. Price($)
1 29183 9.9¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 249372 10
View Market Depth
Last trade - 15.40pm 30/04/2024 (20 minute delay) ?
Last
10.0¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
10.0¢ 10.0¢ 10.0¢ 45446
Last updated 15.40pm 30/04/2024 ?

Top Stories

Recharged Prospects: 'Watts' on the horizon for copper & lithium

The conversation goes much deeper that this title suggests - it explores everything from projections on aluminium & manganese, to what a Donald Trump government could mean for commodities markets.
Lithium Universe ends the quarter charged up for Quebec Refinery roll-out Lithium Universe has closed off the March quarter with a new Chief Financial Officer and strategically located land anchored for its lithium refinery in Quebec, Canada.
Carnarvon revs up for revised Dorado Development The Dorado discovery appears on again, with Carnarvon Energy announcing the JV completing a revision of the project’s design to optimise capital costs and accelerate FID by the end of 2024.
Why Princeton Professor rates BlinkLab's autism & ADHD screening app In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab's (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD.
Provident Aurum's off-market bid sends Sihayo shares soaring Small-cap mineral and gold explorer, Sihayo Gold (ASX:SIH) shares have soared, on news that the company has received intentions from Provident Aurum Pte to make an off-market takeover offer to acquire all shares of Sihayo Gold.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.